Literature DB >> 8581979

Neurobiology and clinical aspects of neuropeptide Y.

M Heilig1, E Widerlöv.   

Abstract

Although a large and still increasing number of neuroactive peptides have been discovered in the mammalian brain over the years, it has been difficult to link most of these molecules with specific brain functions and/or brain diseases. A lack of pharmacological tools has hampered the study of brain peptide systems and the elucidation of which among these systems have retained important physiological functions through phylogenesis. Neuropeptide Y (NPY) is one the most abundant neuropeptides in the mammalian brain. A combination of basic and clinical studies has made it possible to circumvent some of these difficulties and provides evidence for a role of NPY in the control of endocrine hypothalamic and pituitary functions, in hypothalamic control of food intake and circadian rhythm, and in limbic emotional integration. Of particular interest is NPY's unique action as an endogenous anxiolytic and its possible role in clinical states of anxiety and depression. Here, we review the biology, anatomy, and physiology of central NPY systems and studies of these systems in various disease states.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581979

Source DB:  PubMed          Journal:  Crit Rev Neurobiol        ISSN: 0892-0915


  26 in total

1.  Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control.

Authors:  K A Nichol; A Morey; M H Couzens; J Shine; H Herzog; A M Cunningham
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist.

Authors:  Y Dumont; A Cadieux; H Doods; L H Pheng; R Abounader; E Hamel; D Jacques; D Regoli; R Quirion
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

3.  Effects of electroconvulsive stimuli and MK-801 on neuropeptide Y, neurokinin A, and calcitonin gene-related peptide in rat brain.

Authors:  A A Mathé; S Gruber; P A Jiménez; E Theodorsson; C Stenfors
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

4.  Neuropeptide expression in rats exposed to chronic mild stresses.

Authors:  Valeriy Sergeyev; Serguei Fetissov; Aleksander A Mathé; Patricia A Jimenez; Tamas Bartfai; Patrick Mortas; Laurent Gaudet; Jean-Luc Moreau; Tomas Hökfelt
Journal:  Psychopharmacology (Berl)       Date:  2004-10-30       Impact factor: 4.530

Review 5.  A Critical Review of Methods and Results in the Search for Genetic Contributors to Alcohol Sensitivity.

Authors:  Marc A Schuckit
Journal:  Alcohol Clin Exp Res       Date:  2018-04-05       Impact factor: 3.455

6.  Differential pre- and postsynaptic modulation of chemical transmission in the squid giant synapse by tyrosine phosphorylation.

Authors:  R Llinás; H Moreno; M Sugimori; M Mohammadi; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

7.  Neuropeptide Y Y2 antagonist treated ovariectomized mice exhibit greater bone mineral density.

Authors:  K L Seldeen; P G Halley; C H Volmar; M A Rodríguez; M Hernandez; M Pang; S K Carlsson; L J Suva; C Wahlestedt; B R Troen; S P Brothers
Journal:  Neuropeptides       Date:  2017-11-07       Impact factor: 3.286

8.  Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence.

Authors:  Leah Wetherill; Marc A Schuckit; Victor Hesselbrock; Xiaoling Xuei; Tiebing Liang; Danielle M Dick; John Kramer; John I Nurnberger; Jay A Tischfield; Bernice Porjesz; Howard J Edenberg; Tatiana Foroud
Journal:  Alcohol Clin Exp Res       Date:  2008-09-25       Impact factor: 3.455

9.  NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons.

Authors:  Andrei I Molosh; Tammy J Sajdyk; William A Truitt; Weiguo Zhu; Gerry S Oxford; Anantha Shekhar
Journal:  Neuropsychopharmacology       Date:  2013-01-28       Impact factor: 7.853

10.  Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.

Authors:  L Criscione; P Rigollier; C Batzl-Hartmann; H Rüeger; A Stricker-Krongrad; P Wyss; L Brunner; S Whitebread; Y Yamaguchi; C Gerald; R O Heurich; M W Walker; M Chiesi; W Schilling; K G Hofbauer; N Levens
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.